Stay updated on Xilonix for Symptomatic Colorectal Cancer: Clinical Trial
Sign up to get notified when there's something new on the Xilonix for Symptomatic Colorectal Cancer: Clinical Trial page.

Latest updates to the Xilonix for Symptomatic Colorectal Cancer: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe Publications section now specifies that listed publications are about the results of the study, and the revision tag updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check20 days agoChange DetectedRemoved the general government funding status notice from the page, a site-wide banner that does not affect the study details, eligibility criteria, or enrollment information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check34 days agoChange DetectedBoth screenshots display the same study page with the core details (title, NCT number, eligibility criteria, and outcomes) unchanged. The differences appear to be visual/layout changes that do not alter the page’s substantive content.SummaryDifference0.4%

- Check63 days agoChange DetectedUpdated page now includes a government-operating-status notice and a new 3.2.0 revision, replacing the prior 3.1.0 revision.SummaryDifference4%

- Check70 days agoChange DetectedUpdated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the older version tag v3.0.2, suggesting a reorganization of content around a new version.SummaryDifference0.5%

- Check85 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.3%

Stay in the know with updates to Xilonix for Symptomatic Colorectal Cancer: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Xilonix for Symptomatic Colorectal Cancer: Clinical Trial page.